Alice D.  Schroeder net worth and biography

Alice Schroeder Biography and Net Worth

Director of Natus Medical
Alice Schroeder serves on the board of Natus Medical, Prudential PLC, and Quorum Health Corporation. She chairs the Natus Nominating and Governance committee and serves on its audit committee, and chairs the Quorum audit and compliance committee and serves on its nominating and governance committee. She serves on the Prudential plc audit committee and on its risk committee. Before its merger into an Irish affiliate in anticipation of Brexit, Ms. Schroeder chaired Bank of America Merrill Lynch International's (“BAMLI”) audit committee and served on its governance committee. She chaired the audit committee of Cetera Financial Group before its sale to RCS Capital. 

Ms. Schroeder was CEO and chair from 2014-2017 of WebTuner Corp., a Seattle-area software developer, through its turnaround and exit through sale in May 2017. Formerly, she was a Managing Director in the equities division of Morgan Stanley, leading the global insurance research team, and before that at PaineWebber and CIBC Oppenheimer, spending nearly two decades on Wall Street. She began her career as a CPA with Ernst & Young and spent two years as a project manager at the Financial Accounting Standards Board, overseeing the issuance of several key accounting standards for the insurance industry.

What is Alice D. Schroeder's net worth?

The estimated net worth of Alice D. Schroeder is at least $8.20 million as of May 26th, 2023. Ms. Schroeder owns 248,769 shares of Natus Medical stock worth more than $8,199,426 as of April 20th. This net worth estimate does not reflect any other assets that Ms. Schroeder may own. Learn More about Alice D. Schroeder's net worth.

How do I contact Alice D. Schroeder?

The corporate mailing address for Ms. Schroeder and other Natus Medical executives is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. Natus Medical can also be reached via phone at (608) 829-8500 and via email at [email protected]. Learn More on Alice D. Schroeder's contact information.

Has Alice D. Schroeder been buying or selling shares of Natus Medical?

Alice D. Schroeder has not been actively trading shares of Natus Medical during the last quarter. Most recently, Alice D. Schroeder sold 2,934 shares of the business's stock in a transaction on Friday, June 11th. The shares were sold at an average price of $27.49, for a transaction totalling $80,655.66. Following the completion of the sale, the director now directly owns 12,117 shares of the company's stock, valued at $333,096.33. Learn More on Alice D. Schroeder's trading history.

Who are Natus Medical's active insiders?

Natus Medical's insider roster includes D. Christopher Chung (VP), and Alice Schroeder (Director). Learn More on Natus Medical's active insiders.

Alice D. Schroeder Insider Trading History at Natus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2021Sell2,934$27.49$80,655.6612,117View SEC Filing Icon  
See Full Table

Alice D. Schroeder Buying and Selling Activity at Natus Medical

This chart shows Alice D Schroeder's buying and selling at Natus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Natus Medical Company Overview

Natus Medical logo
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
Read More

Today's Range

Now: $32.96
Low: $32.96
High: $32.96

50 Day Range

MA: $32.96
Low: $32.96
High: $32.96

2 Week Range

Now: $32.96
Low: $20.90
High: $33.93

Volume

1,514 shs

Average Volume

325,002 shs

Market Capitalization

$1.14 billion

P/E Ratio

89.08

Dividend Yield

N/A

Beta

0.22